Literature DB >> 2621584

Ion-paired reversed-phase high-performance liquid chromatography assay for determination of ceftriaxone in human plasma and urine.

G L Jungbluth1, W J Jusko.   

Abstract

A rapid, sensitive, and specific ion-paired reversed-phase HPLC assay for ceftriaxone in human plasma and urine is described. Small volumes (50 microL) of sample are deproteinized with acetonitrile and are directly injected on a C18 analytical column. The UV absorbance is monitored at 280 nm. The assay is linear between 1 and 125 micrograms/mL of ceftriaxone, with less than 10% coefficient of both intra- and interday variation. Chromatography was specific for ceftriaxone as endogenous compounds and 30 common drugs did not interfere. The assay was used in open heart surgery patients where potential interference from corticosteroids was overcome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2621584     DOI: 10.1002/jps.2600781118

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis.

Authors:  X Sáez-Llorens; H S Jafari; C Severien; F Parras; K D Olsen; E J Hansen; I I Singer; G H McCracken
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

2.  Spectrofluorimetric protocol for ceftriaxone in commercial formulation and human plasma after condensation with formaldehyde and ethyl acetoacetate.

Authors:  Jasmin Shah; M Rasul Jan; Sultan Shah; M Naeem
Journal:  J Fluoresc       Date:  2011-07-12       Impact factor: 2.217

3.  Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.

Authors:  I Lutsar; A Ahmed; I R Friedland; M Trujillo; L Wubbel; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

4.  Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model.

Authors:  S M Palmer; S L Kang; D M Cappelletty; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

5.  A novel high performance liquid chromatographic method for simultaneous determination of ceftriaxone and sulbactam in sulbactomax.

Authors:  Sanjay Mohan Shrivastava; Rajkumar Singh; Abu Tariq; Masoom Raza Siddiqui; Jitendar Yadav; P S Negi; Manu Chaudhary
Journal:  Int J Biomed Sci       Date:  2009-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.